NCT02536339 · Interventional trial
A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy
Overall registry status Completed
Phase 2
Conditions Metastatic Breast Cancer
Delaware Valley sites
- Temple Cancer Center; Oncology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory